Amanda Marie Morrison

Amanda Marie Morrison

Auto-generated profile, based on publicly available information

Amanda Marie Morrison

Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
AMAmanda M. Morrison
Amanda M. Morrison
SHShi Huang
Shi Huang
JAJeffrey S. Annis
Jeffrey S. Annis
JGJonah D. Garry
Jonah D. Garry
AHAnna R. Hemnes
Anna R. Hemnes
EBEvan L. Brittain
Evan L. Brittain
Background: Pulmonary hypertension and right ventricular (RV) dysfunction are drivers of adverse outcomes; however, modifiable risk factors for RV dysfunction are not well described. We investigated the association between clinical markers of metabolic syndrome and echocardiographic RV function in a large referral population. Methods and Results: Using electronic health record data, we performed a retrospective cohort study of patients aged ≥18 years referred for transthoracic echocardiography between 2010 and 2020 with RV systolic pressure (RVSP) or tricuspid annular plane systolic excursion (TAPSE) values. Pulmonary hypertension was defined by RVSP >33 mm Hg and RV dysfunction by TAPSE ≤1.8 cm. Our sample included 37 203 patients of whom 19 495 (52%) were women, 29 752 (83%) were White, with a median age of 63 years (interquartile range, 51–73). Median (interquartile range) RVSP was 30.0 mm Hg (24.0–38.7), and median TAPSE was 2.1 cm (1.7–2.4). Within our sample, 40% had recorded RVSP >33 mm Hg, and 32% with TAPSE <1.8 cm. Increase in RVSP from normal (39 mm Hg) was associated with lower low‐density lipoprotein and high‐density lipoprotein, and higher hemoglobin A1c and body mass index ( P 1.8 cm, TAPSE 1.5–1.8 cm, and TAPSE <1.5 cm was associated with increased triglyceride:high‐density lipoprotein ratio and hemoglobin A1c, and decreased body mass index, low‐density lipoprotein, high‐density lipoprotein, and systolic blood pressure ( P <0.001). Most associations between cardiometabolic predictors and RVSP and TAPSE were nonlinear with clear inflection points associated with higher pulmonary pressure and lower RV function. Conclusions: Clinical measures of cardiometabolic function were highly associated with echocardiographic measures of right ventricular function and pressure.

15 January 2019 in Journal of Neurotrauma
Verified
Journal Article
Closed access
AMAmanda Marie Morrison
Amanda Marie Morrison
AHAmy Joy Houtrow
Amy Joy Houtrow
JZJames Zullo
James Zullo
PKPatrick M. Kochanek
Patrick M. Kochanek
CVCarol Vetterly
Carol Vetterly
EFEricka L. Fink
Ericka L. Fink
Neurostimulant medications are commonly prescribed following traumatic brain injury (TBI) in adults; little is known about their use in children with TBI. Our objective was to analyze neurostimulant prescribing practices from 2005 to 2015 in children admitted to the intensive care unit (ICU) with TBI. We hypothesized that neurostimulant prescriptions have increased over time and are associated with older age and injury severity. A retrospective cohort study of patients aged 1 month to 18 years with an ICD-9-CM discharge diagnosis code for TBI admitted to the ICU between 2005 and 2015 in 37 pediatric hospitals included in the Pediatric Health Information System was conducted. Variables examined include patient and injury characteristics and neurostimulant medication use. Descriptive statistics and multivariable logistic regression testing were used to determine variables associated with neurostimulant prescription. Of 30,881 patients with TBI, most were male (64%) and aged 0-4 years (43%). In patients with mechanism of injury reported (n=21,998), TBI was most frequently due to falls (36%) and motor vehicle collisions (36%). 1,064 neurostimulants were prescribed to 878 (3%) patients with 41% of prescriptions for amantadine and 38% for methylphenidate. Neurostimulants were prescribed a median (interquartile range) of 17 (8-35) days post-injury and increased over the study decade (R2=0.806). In a multivariable analysis, variables most strongly associated with receipt of a neurostimulant were age 14-18 years (odds ratio 5.8, 95% confidence interval [4.3,7.8]), motor vehicle collision (3.1, [2.4,4.2]), intracranial pressure monitor (3.8, [3.1,4.5]), and mechanical ventilation (3.4, [2.7,4.3]). Use of neurostimulants following pediatric TBI is uncommon, has increased over time, and is associated with indicators of higher severity of illness. Knowledge of prescribing practices may assist in optimizing the design of efficacy and outcome studies that will inform clinical guidelines.